×
ADVERTISEMENT

glioblastoma multiforme

Success of New Modality in GBM May Be Relevant to Other Ca

Washington—A new type of treatment that improved overall survival (OS) in patients with newly diagnosed ...

MAY 17, 2017

FDA Grants Orphan Drug Designation to EDV Nanocells for GBM

Epidermal growth factor receptor (EGFR)-targeted, doxorubicin-loaded EDV nanocells (EnGeneIC) granted orphan ...

MARCH 2, 2017

Load more